Clinical Trials Browser

Phase 2 × Metastatic Castration-resistant Prostate Cancer × enzalutamide × Clear all

NCT06228053 2025-12-22

SYNERGY-201

Phase 2 Recruiting

Metastatic Castration-resistant Prostate Cancer

NCT03770455 2024-07-09

Avelumab Plus 2nd-generation ADT in African American Subjects With mCRPC

Phase 2 Terminated

8 enrolled 7 charts

Metastatic Castration-resistant Prostate Cancer